Back to search

Eyevision Pharma Ltd

14839659

active
Private Limited Company
england wales
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk

No risk factors detected.

Details

128 CITY ROAD, LONDON, EC1V 2NX
Incorporated 02/05/2023

Compliance

Last accounts

31/05/2025

micro entity

Next accounts due

28/02/2027

On track

Confirmation statement

Last: 01/05/2025

Due 15/05/2026

Overdue

Industry

72110
Research and experimental development on biotechnology

Officers

Dorotheus Biotech Inc

director · Since 02/05/2023

Mr Roger Bendelac

director · Since 01/08/2025

BUSINESS EXECUTIVE

AMERICAN · UNITED STATES · Age 69

Former

Dr Sridhar Prasad

director · Resigned 01/08/2026

Persons with Significant Control

Sridhar Prasad

50–75% votes

12236, Ragweed St, San Diego

Reg: 2023-001223569 · Wyoming · Corporation

Notified 02/05/2023

CompanyRankvs 1616+ SIC 72110 peers
49

Financial strength77th percentile among SIC peers · 19/25
Employees77th percentile among SIC peers · 12/15
LiquidityNo balance sheet data · 0/20
Longevity3 years trading (max 15) · 3/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength19/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees12/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity0/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity3/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/05/2025

Net Worth

£71k

Balance sheet strength

Cash

Cash in the bank

Net Current Assets

£0

Working capital

Current Assets

Current Liabilities

Fixed Assets

£71k

3avg. employees+2

Balance Sheet

Assets less current liabilities£71k
Prepared with Companies House

EstimatesDerived

YearImplied Profit
2025-£9k

Derived from filed accounts. Not audited figures.